Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

被引：0
|
作者：
J. Lee
Y. H. Im
S. H. Lee
E. Y. Cho
Y. L. Choi
Y. H. Ko
J. H. Kim
S. J. Nam
H. J. Kim
J. S. Ahn
Y. S. Park
H. Y. Lim
B. K. Han
J. H. Yang
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center
[2] Sungkyunkwan University School of Medicine,Department of Pathology, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Department of Surgery, Samsung Medical Center
[4] Sungkyunkwan University School of Medicine,Department of Radiology and Center for Imaging Science, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Ki-67 proliferation index; Breast cancer; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：569 / 577
页数：8
相关论文
共 50 条
  • [41] Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer
    Luo, Ningbin
    Ji, Yinan
    Huang, Xiangyang
    Liu, Yu
    Liu, Lidong
    Jin, Guanqiao
    Zhao, Xin
    Zhu, Xuna
    Su, Danke
    ACADEMIC RADIOLOGY, 2019, 26 (10) : 1352 - 1357
  • [42] Prognostic significance of Ki-67 index value at the primary breast tumor in recurrent breast cancer
    Nishimura, Reiki
    Osako, Tomofumi
    Nishiyama, Yasuyuki
    Tashima, Rumiko
    Nakano, Masahiro
    Fujisue, Mamiko
    Toyozumi, Yasuo
    Arima, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (06) : 1062 - 1068
  • [43] Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience
    Roge, Rasmus
    Nielsen, Soren
    Riber-Hansen, Rikke
    Vyberg, Mogens
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (02) : 99 - 104
  • [44] Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer
    Saritas, Ahmet Gokhan
    Yalav, Orcun
    Kekec, Yalcin
    Sakman, Gurhan
    Kilic, Emine Bagir
    Zorludemir, Suzan
    Ergin, Melek
    Eray, Tsmail Cem
    Kara, Tsmail Oguz
    Paydas, Semra
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (01): : 226 - 231
  • [45] Prospective Evaluation of Response Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Ashok, A.
    Sude, Nandkishor Sopanrao
    Rakesh, B. A.
    Karanam, Venkata Pavan Kumar
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [46] Histopathologic changes following neoadjuvant chemotherapy in locally advanced breast cancer
    Sethi, D.
    Sen, R.
    Parshad, S.
    Khetarpal, S.
    Garg, M.
    Sen, J.
    INDIAN JOURNAL OF CANCER, 2013, 50 (01) : 58 - 64
  • [47] Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant Chemotherapy
    Heayn, Michelle
    Skvarca, Lauren B.
    Zhu, Li
    Edwards, Robert P.
    Olawaiye, Alexander B.
    Modugno, Francesmary
    Elishaev, Esther
    Bhargava, Rohit
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (03) : 278 - 285
  • [48] Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer
    Li, Xi-ru
    Liu, Mei
    Zhang, Yan-jun
    Wang, Jian-dong
    Zheng, Yi-qiong
    Li, Jie
    Ma, Bing
    Song, Xin
    MEDICAL ONCOLOGY, 2011, 28 : S31 - S38
  • [49] Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer
    Xi-ru Li
    Mei Liu
    Yan-jun Zhang
    Jian-dong Wang
    Yi-qiong Zheng
    Jie Li
    Bing Ma
    Xin Song
    Medical Oncology, 2011, 28 : 31 - 38
  • [50] Combination of shear wave elastography and Ki-67 index as a novel predictive modality for the pathological response to neoadjuvant chemotherapy in patients with invasive breast cancer
    Ma, Yan
    Zhang, Shuo
    Zang, Li
    Li, Jing
    Li, Jianyi
    Kang, Ye
    Ren, Weidong
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : 86 - 101
12345